Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The ILAILL study: iloprost as adjuvant to surgery for acute ischemia of lower limbs: a randomized, placebo-controlled, double-blind study by the italian society for vascular and endovascular surgery.
de Donato G, Gussoni G, de Donato G, Andreozzi GM, Bonizzoni E, Mazzone A, Odero A, Paroni G, Setacci C, Settembrini P, Veglia F, Martini R, Setacci F, Palombo D. de Donato G, et al. Among authors: bonizzoni e. Ann Surg. 2006 Aug;244(2):185-93. doi: 10.1097/01.sla.0000217555.49001.ca. Ann Surg. 2006. PMID: 16858180 Free PMC article. Clinical Trial.
Acute limb ischemia in elderly patients: can iloprost be useful as an adjuvant to surgery? Results from the ILAILL study.
de Donato G, Gussoni G, de Donato G, Cao P, Setacci C, Pratesi C, Mazzone A, Ferrari M, Veglia F, Bonizzoni E, Settembrini P, Ebner H, Martino A, Palombo D; Ilaill Study Group. de Donato G, et al. Among authors: bonizzoni e. Eur J Vasc Endovasc Surg. 2007 Aug;34(2):194-8. doi: 10.1016/j.ejvs.2007.02.002. Epub 2007 Apr 11. Eur J Vasc Endovasc Surg. 2007. PMID: 17433732 Free article. Clinical Trial.
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.
Agnelli G, Gussoni G, Bianchini C, Verso M, Mandalà M, Cavanna L, Barni S, Labianca R, Buzzi F, Scambia G, Passalacqua R, Ricci S, Gasparini G, Lorusso V, Bonizzoni E, Tonato M; PROTECHT Investigators. Agnelli G, et al. Among authors: bonizzoni e. Lancet Oncol. 2009 Oct;10(10):943-9. doi: 10.1016/S1470-2045(09)70232-3. Epub 2009 Aug 31. Lancet Oncol. 2009. PMID: 19726226 Clinical Trial.
Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study.
Barni S, Labianca R, Agnelli G, Bonizzoni E, Verso M, Mandalà M, Brighenti M, Petrelli F, Bianchini C, Perrone T, Gasparini G. Barni S, et al. Among authors: bonizzoni e. J Transl Med. 2011 Oct 20;9:179. doi: 10.1186/1479-5876-9-179. J Transl Med. 2011. PMID: 22013950 Free PMC article. Clinical Trial.
Effects of iloprost on pain-free walking distance and clinical outcome in patients with severe stage IIb peripheral arterial disease: the FADOI 2bPILOT Study.
Mazzone A, Di Salvo M, Mazzuca S, Valerio A, Gussoni G, Bonizzoni E, Campanini M, Vescovo G, Nozzoli C; FADOI 2bPILOT Study Group. Mazzone A, et al. Among authors: bonizzoni e. Eur J Clin Invest. 2013 Nov;43(11):1163-70. doi: 10.1111/eci.12159. Epub 2013 Sep 17. Eur J Clin Invest. 2013. PMID: 24102344 Clinical Trial.
119 results